Outset Medical
152 hedge funds and large institutions have $2.33B invested in Outset Medical in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 43 reducing their positions, and 22 closing their positions.
254% more call options, than puts
Call options by funds: $10.1M | Put options by funds: $2.86M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
49% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 43
4% more capital invested
Capital invested by funds: $2.24B → $2.33B (+$90.3M)
0.34% more ownership
Funds ownership: 6.88% → 7.21% (+0.34%)
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
3% less funds holding
Funds holding: 156 → 152 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$58.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.5M |
| 4 |
Bank of New York Mellon
New York
|
+$8.64M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$16.6M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$8.8M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$8.54M |
| 4 |
Morgan Stanley
New York
|
-$8.37M |
| 5 |
Renaissance Technologies
New York
|
-$6.36M |
OM Hedge Fund Activity: Q1 2022 in Review
152 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2022, worth a combined $2.33B — up 4% from $2.24B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of OM and 20 opened new positions — a net loss of 2 holders — while 43 trimmed existing stakes and 64 added.
The largest buyer was Bellevue Group, adding an estimated $58.4M. The largest seller was BlackRock, cutting an estimated $16.6M.
- 152 institutional investors held Outset Medical (OM) as of Q1 2022, down from 156 in Q4 2021.
- Funds reported $2.33B of Outset Medical stock for Q1 2022, up 4% quarter-over-quarter.
- 20 funds opened new Outset Medical positions in Q1 2022 and 22 closed out, a net change of -2 holders.
- The largest Outset Medical buyer in Q1 2022 was Bellevue Group, an estimated $58.4M added.
- The largest Outset Medical seller in Q1 2022 was BlackRock, an estimated $16.6M sold.
Based on aggregated 13F filings for Q1 2022.